Academic literature on the topic 'Pustulose palmoplantaire'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pustulose palmoplantaire.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pustulose palmoplantaire"

1

Marsan, F. M., S. Hiret, M. Saint Jean, and L. Peuvrel. "Pustulose palmoplantaire unilatérale sous avélumab." Annales de Dermatologie et de Vénéréologie 146, no. 12 (2019): A152—A153. http://dx.doi.org/10.1016/j.annder.2019.09.198.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Danion, F., E. Bui, P. Riegel, et al. "Pustulose palmoplantaire fébrile au retour d’Ibiza." La Revue de Médecine Interne 32 (December 2011): S336—S337. http://dx.doi.org/10.1016/j.revmed.2011.10.061.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Obeid, G., G. Do-Pham, E. Sbidian, and L. Le Cleach. "Interventions dans la pustulose palmoplantaire : revue systématique Cochrane." Annales de Dermatologie et de Vénéréologie 145, no. 12 (2018): S131. http://dx.doi.org/10.1016/j.annder.2018.09.150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

EL Bez, I., D. Ben Sellem, I. Slim, et al. "Acnée et pustulose palmoplantaire : pensez au syndrome Sapho." Annales de Dermatologie et de Vénéréologie 140 (April 2013): S55. http://dx.doi.org/10.1016/j.annder.2013.01.052.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Razera, Fernanda, Gislaine Silveira Olm, and Renan Rangel Bonamigo. "Dermatoses neutrofílicas: parte II." Anais Brasileiros de Dermatologia 86, no. 2 (2011): 195–211. http://dx.doi.org/10.1590/s0365-05962011000200001.

Full text
Abstract:
Neste artigo são abordadas as dermatoses neutrofílicas, complementando o artigo anterior (parte I). São apresentadas e comentadas as seguintes dermatoses: pustulose subcórnea de Sneddon-Wilkinson, dermatite crural pustulosa e atrófica, pustulose exantemática generalizada aguda, acroder matite contínua de Hallopeau, pustulose palmoplantar, acropustulose infantil, bacteride pustular de Andrews e foliculite pustulosa eosinofílica. Uma breve revisão das dermatoses neutrofílicas em pacientes pediátricos também é realizada.
APA, Harvard, Vancouver, ISO, and other styles
6

Rueda-Gotor, Javier, Miguel A. González-Gay, Ricardo Blanco, Carmen Gonzalez-Vela, Cristina Lopez-Obregon та Marcos A. González-López. "Effet bénéfique du tocilizumab dans la pustulose palmoplantaire induite par anti-TNF-α au cours de la polyarthrite rhumatoïde". Revue du Rhumatisme 79, № 5 (2012): 469–72. http://dx.doi.org/10.1016/j.rhum.2012.08.006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dantas, Aline Rodrigues, Wollia Monik Vaz Fernandes, Edilberto Vasconcelos Pereira Júnior, and Nicole Rangely Nogueira Martins De Carvalho. "Psoríase pustulosa palmoplantar na infância: um relato de caso." Revista de Patologia do Tocantins 4, no. 3 (2017): 43. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p43.

Full text
Abstract:
Introdução: A psoríase pustulosa palmoplantar, também conhecida como pustulose palmoplantar (PPP) é uma forma de dermatose psoriasiforme caracterizada por erupções de pústulas estéreis de localização palmoplantar e simétrica. Sua prevalência é estimada entre 0,01 a 0,05%, afetando principalmente adultos do sexo feminino entre a sexta e a sétima décadas de vida. A doença é rara na faixa etária pediátrica. Desenvolvimento: No presente trabalho foi relatado um raro caso de PPP, em criança de 6 anos, destacando seu manejo hospitalar e atentando para sua dificuldade diagnóstica. Conclusão: o diagnó
APA, Harvard, Vancouver, ISO, and other styles
8

Marovt, Maruška, and Pij B. Marko. "Apremilast monotherapy for palmoplantar pustulosis: Report of three cases." SAGE Open Medical Case Reports 9 (January 2021): 2050313X2110349. http://dx.doi.org/10.1177/2050313x211034926.

Full text
Abstract:
Palmoplantar pustulosis or palmoplantar pustular psoriasis is chronic skin conditions, characterised by eruptions of sterile pustules on an erythematosquamous background. High-quality data on the treatment of palmoplantar pustulosis are limited, and none is accepted as being effective in general. Apremilast is a small molecule inhibitor of phosphodiesterase 4 approved for the treatment of plaque psoriasis and psoriatic arthritis. We report three cases of palmoplantar pustulosis treated with apremilast monotherapy. Our three cases, as well as previous reports, demonstrate the potential for apre
APA, Harvard, Vancouver, ISO, and other styles
9

Dulski, Anne, and Vince Varamo. "Palmoplantar Pustulosis: A Case Report." Clinical Practice and Cases in Emergency Medicine 4, no. 4 (2020): 664–67. http://dx.doi.org/10.5811/cpcem.2020.7.48476.

Full text
Abstract:
Introduction: Dermatology complaints account for 3.3% of emergency department (ED) visits per year. Most rashes are benign, but there are a select few that emergency physicians must be familiar with as delay in treatment could be life threatening. Case Report: A well-appearing, 76-year-old male presented to the ED with multiple coalescing pustules to his palms and soles and was transferred to the nearest tertiary care hospital for dermatology consult. He was diagnosed with palmoplantar pustulosis and discharged home with a five-day course of clobetasol propionate 0.05% cream twice daily and ou
APA, Harvard, Vancouver, ISO, and other styles
10

Karadaglić, Đorđije, and Silvija Brkić. "Palmoplantar pustulosis – is there any progress in the treatment? / Palmoplantarna pustuloza – ima li pomaka u lečenju?" Serbian Journal of Dermatology and Venerology 3, no. 3 (2011): 101–8. http://dx.doi.org/10.2478/v10249-011-0041-9.

Full text
Abstract:
Abstract Despite, the fact that palmoplantar pustulosis is still widely known by this name, it is currently regarded as a disease distinct from psoriasis. The real cause is still unknown. Septic foci have been blamed, but their removal may not cure eruptions. A case series of de novo occurrence of palmoplantar pustulosis induced by tumor necrosis factor-alpha antagonist therapy has been reported. It has been shown that stress may be related to exacerbation of palmoplantar pustulosis. Some authors suggest that palmoplantar pustulosis is an autoimmune disease. In sera of patients with palmoplant
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pustulose palmoplantaire"

1

CHAMMAT, SAID. "Pustulose palmo-plantaire et osteo-arthropathies." Nice, 1989. http://www.theses.fr/1989NICE6503.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

HIET, ERIC. "Pustuloses palmo-plantaires : manifestations osteoarticulaires." Reims, 1990. http://www.theses.fr/1990REIMM019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

GHRENASSIA, YVES. "Les manifestations osteo-articulaires des pustuloses palmo-plantaires : a propos d'une serie de 17 cas." Toulouse 3, 1990. http://www.theses.fr/1990TOU31116.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

VEDRENNE, CORINNE. "Le rhumatisme de la pustulose palmo-plantaire : etude personnelle de 27 cas." Toulouse 3, 1992. http://www.theses.fr/1992TOU31547.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

NGUYEN, MINH-DUC. "Osteo-arthrite pustuleuse ou syndrome de sonozaki : a propos d'une observation." Aix-Marseille 2, 1989. http://www.theses.fr/1989AIX20061.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

DEPERNET, BERTRAND. "Osteoarthrites pustuleuses et s. A. P. H. O. : etude critique a propos de 11 observations." Reims, 1991. http://www.theses.fr/1991REIMMO98.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

MENTRE, ARNAUD. "Le sapho : a propos de 8 observations." Lille 2, 1993. http://www.theses.fr/1993LIL2M321.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Assy, Najib [Verfasser]. "Immunhistochemische Analyse der Psoriasis palmoplantaris pustulosa / Najib Assy." Mainz : Universitätsbibliothek Mainz, 2019. http://d-nb.info/1201508975/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hagforsen, Eva. "Palmoplantar pustulosis : pathogenetic studies with special reference to the role of nicotine /." Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2001. http://publications.uu.se/theses/91-554-4955-7/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hagforsen, Eva. "Pamoplantar Pustulosis. Pathogenetic Studies with Special Reference to the Role of Nicotine." Doctoral thesis, Uppsala universitet, Institutionen för medicinska vetenskaper, 2001. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-607.

Full text
Abstract:
Palmoplantar pustulosis (PPP) is a chronic disease of unknown pathogenesis. Most of the patients were smokers. High prevalence of a number of autoimmune diseases was observed among the patients (thyroid disease 14%, gluten intolerance 8%, diabetes type 1 3%). Eosinophils and neutrophils were found in large numbers in the pustules. Massive infiltrates of lymphocytes and mast cells in the dermis below the pustule and an abnormal acrosyringial pattern indicate that the acrosyringium is the target for the inflammation. Immunofluorescence (IF) revealed decreased innervation of the sweat gland, outw
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pustulose palmoplantaire"

1

Korstanje, M. J. "Hoe behandelt men pustulosis palmoplantaris?" In Vademecum permanente nascholing huisartsen. Bohn Stafleu van Loghum, 2006. http://dx.doi.org/10.1007/978-90-313-8808-0_143.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pigatto, Paolo D., and Gianpaolo Guzzi. "Metal Allergy and Palmoplantar Pustulosis." In Metal Allergy. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-58503-1_42.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Takahara, Miki. "Clinical Outcome of Tonsillectomy for Palmoplantar Pustulosis and Etiological Relationship between Palmoplantar Pustulosis and Tonsils." In Recent Advances in Tonsils and Mucosal Barriers of the Upper Airways. KARGER, 2011. http://dx.doi.org/10.1159/000324618.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Harabuchi, Yasuaki. "Clinical Manifestations and Pathogenesis of Tonsillar Focal Diseases: IgA Nephropathy and Palmoplantar Pustulosis." In Recent Advances in Tonsils and Mucosal Barriers of the Upper Airways. KARGER, 2011. http://dx.doi.org/10.1159/000324583.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yamamoto, Toshiyuki. "Triggering Role of Focal Infection in the Induction of Extra-Palmoplantar Lesions and Pustulotic Arthro-Osteitis Associated with Palmoplantar Pustulosis." In Recent Advances in Tonsils and Mucosal Barriers of the Upper Airways. KARGER, 2011. http://dx.doi.org/10.1159/000324620.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

de Rie, M. A. "A New Psoralen-Containing Gel for Topical PUVA Therapy: Development and Treatment Results with Palmoplantar and Plaque-Type Psoriasis, Pustulosis Palmaris et Plantaris and Chronic/Hyperkeratotic Eczema." In Skin Cancer and UV Radiation. Springer Berlin Heidelberg, 1997. http://dx.doi.org/10.1007/978-3-642-60771-4_45.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"Palmoplantar Pustulosis." In Diagnostic Pathology: Nonneoplastic Dermatopathology. Elsevier, 2017. http://dx.doi.org/10.1016/b978-0-323-37713-3.50050-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"Palmoplantar pustulosis." In Dermatology Therapy. Springer Berlin Heidelberg, 2004. http://dx.doi.org/10.1007/3-540-29668-9_2017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Moinzadeh, Pia, and Thomas Krieg. "Neutrophilic dermatoses." In Oxford Textbook of Rheumatology. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0166.

Full text
Abstract:
Neutrophilic dermatoses (ND) comprise a group of non-infectious skin diseases characterized by a diffuse epidermal and/or dermal infiltrate consisting of polymorphonuclear neutrophilic inflammatory cells throughout the different skin layers. Depending on the localization of this infiltrate, patients may present with a variety of skin lesions such as pustules/vesiculopustules (epidermal infiltrate), plaques or papules (dermal infiltration), nodules or ulcerations (deep dermal/subcutaneous infiltrate) and also with possible systemic symptoms, such as leucocytosis, arthralgias, myalgia, and malaise. Depending on the localization of neutrophilic cells in the skin, the clinical picture of cutaneous lesions and further systemic symptoms the patients can be subdivided into different subgroups. These include Sweet’s syndrome (SS), pyoderma gangrenosum (PG), rheumatoid neutrophilic dermatitis, bowel-associated dermatosis-arthritis syndrome, subcorneal pustular dermatosis (Sneddon Wilkinson), acute generalized exanthematous pustulosis (AGEP), acrodermatitis continua of Hallopeau (ACH), palmoplantare pustuloses (PPP), pustular bacterid (PB), neutrophilic eccrine hidradenitis, and Behçet’s disease. The pathogenesis is still not fully elucidated but it has been hypothesized that it is associated with immunological dysfunctions, with abnormal cytokine signalling, causing an uncontrolled recruitment of neutrophilic cells. ND can be triggered by underlying systemic inflammatory diseases, malignancies, haematological disorders and/or medication use. Diagnostic procedures include detailed physical examination, laboratory tests, and histopathological assessments. The therapeutic management of ND includes systemic steroids in acute cases and immunosuppressive or immunomodulatory drugs in chronic forms. Underlying systemic conditions have to be diagnosed and treated.
APA, Harvard, Vancouver, ISO, and other styles
10

Moinzadeh, Pia, and Thomas Krieg. "Neutrophilic dermatoses." In Oxford Textbook of Rheumatology. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0166_update_001.

Full text
Abstract:
Neutrophilic dermatoses (ND) comprise a heterogeneous group of non-infectious skin diseases characterized by a diffuse epidermal and/or dermal infiltrate consisting of polymorphonuclear neutrophilic inflammatory cells throughout the different skin layers. Depending on the localization of this infiltrate, patients may present with a variety of skin lesions such as pustules/vesiculopustules (epidermal infiltrate), plaques or papules (dermal infiltration), nodules or ulcerations (deep dermal/subcutaneous infiltrate) and also with possible systemic symptoms, such as leucocytosis, arthralgias, myalgia, and malaise. Based on the clinical picture of cutaneous lesions and further systemic symptoms the patients can be subdivided into different entities. These include Sweet’s syndrome (SS), pyoderma gangrenosum (PG), rheumatoid neutrophilic dermatitis, bowel-associated dermatosis-arthritis syndrome, subcorneal pustular dermatosis (Sneddon Wilkinson), acute generalized exanthematous pustulosis (AGEP), acrodermatitis continua of Hallopeau (ACH), palmoplantare pustuloses (PPP), pustular bacterid (PB), neutrophilic eccrine hidradenitis, and Behçet’s disease. The pathogenesis is still not fully elucidated but it has been hypothesized that it is associated with immunological dysfunctions, with abnormal cytokine signalling, causing an uncontrolled recruitment of neutrophilic cells. ND can be triggered by underlying systemic inflammatory diseases, malignancies, haematological disorders and/or medication use. Diagnostic procedures include detailed physical examination, laboratory tests, and histopathological assessments. The therapeutic management of ND is mainly based on systemic steroids in acute cases and immunosuppressive or immunomodulatory drugs in chronic forms. Underlying systemic conditions have to be diagnosed and treated as early as possible to avoid complications.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pustulose palmoplantaire"

1

Cortes De Miguel, S., S. Belda-Rustarazo, C. García-Fernández, CM Valencia-Soto, and S. Portillo-Haro. "5PSQ-018 Adalimumab in palmoplantar pustulosis." In 25th EAHP Congress, 25th–27th March 2020, Gothenburg, Sweden. British Medical Journal Publishing Group, 2020. http://dx.doi.org/10.1136/ejhpharm-2020-eahpconf.335.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ruwaard, J., E. van der Vlugt, P. Brevet, et al. "FRI0707 Drug levels and antidrug antibodies in the development of paradoxical psoriasis and palmoplantar pustulosis." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3635.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ruwaard, J., E. van der Vlugt, M. Nurmohamed, T. Rispens, and GJ Wolbink. "SAT0433 Anti-tnf treatment in rheumatoid arthritis and ankylosing spondylitis patients is associated with a strong increase of palmoplantar pustulosis but not of psoriasis vulgaris." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3758.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!